We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Under Investigation Again Over Kickback Scheme
Novartis Under Investigation Again Over Kickback Scheme
July 19, 2013
Novartis’ legal maelstrom surrounding alleged kickbacks just got worse with a fresh federal investigation into the pharma giant’s marketing practices for its oral multiple sclerosis drug Gilenya.